RANITYDYNA AUROVITAS

Q: Is this product safe to consume?

No. This product has been recalled due to: Exceedance of the acceptable limit of N-nitrosodimethylamine (NDMA) contamination was detected and confirmed in products containing Ranitidinum, creating a real, high probability of a threat to patients’ health or life. Potential effects: chronic exposure, carcinogenic effects, liver damage, general poisoning of the body.

Q: Which batches are affected?

Affected batch numbers: NCSA18009-A, NCSA18010-A, NCSA18011-B, NCSA19002-B, NGSA19003-A, NCSA19004-A, NCS$A19009-A, NCSA19016-A, NCSA19017-A

Exceedance of the acceptable limit of N-nitrosodimethylamine (NDMA) contamination was detected and confirmed in products containing Ranitidinum, creating a real, high probability of a threat to patients’ health or life. Potential effects: chronic exposure, carcinogenic effects, liver damage, general poisoning of the body.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

App Store Google Play

Risk Level

Critical

Manufacturer

Aurovitas Pharma Polska Sp. z o.o.

Batch Number

NCSA18009-A, NCSA18010-A, NCSA18011-B, NCSA19002-B, NGSA19003-A, NCSA19004-A, NCS$A19009-A, NCSA19016-A, NCSA19017-A

Recall Date

11.10.2019

What You Should Know

Recommendations

Do not use the product from the listed batches. Patients should check the batch number of their medicine, stop using it, and consult a doctor or pharmacist regarding further treatment and possible ret...

Actions Taken

The Chief Pharmaceutical Inspector withdrew the specified batches of the medicinal product Ranitidine Aurovitas from the market throughout the country, granted the decision immediate enforceability, a...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?

No. This product has been recalled due to: Exceedance of the acceptable limit of N-nitrosodimethylamine (NDMA) contamination was detected and confirmed in products containing Ranitidinum, creating a real, high probability of a threat to patients’ health or life. Potential effects: chronic exposure, carcinogenic effects, liver damage, general poisoning of the body.

What should I do if I already bought this?

Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.

Which batches are affected?

Affected batch numbers: NCSA18009-A, NCSA18010-A, NCSA18011-B, NCSA19002-B, NGSA19003-A, NCSA19004-A, NCS$A19009-A, NCSA19016-A, NCSA19017-A

RANITYDYNA AUROVITAS

What You Should Know

Recommendations

Actions Taken

Need Help?

Frequently Asked Questions

Other Recalled Products

Lorafen

Carmustine Accord

Taromentin

Plerixafor MSN

Zoledronic Acid Noridem